2,4-Dioxochroman Moiety Linked to 1,2,3-triazole Derivatives as Novel α-glucosidase Inhibitors: Synthesis, In vitro Biological Evaluation, and Docking Study

被引:0
作者
Mollazadeh, Marjan [1 ]
Mohammadi-Khanaposhtani, Maryam [2 ]
Valizadeh, Yousef [3 ]
Zonouzi, Afsaneh [1 ]
Faramarzi, Mohammad Ali [4 ]
Hariri, Parsa [4 ]
Biglar, Mahmood [3 ]
Larijani, Bagher [3 ]
Hamedifar, Haleh [5 ]
Mahdavi, Mohammad [3 ]
Sepehri, Nima [6 ]
机构
[1] Univ Tehran, Coll Sci, Sch Chem, Tehran, Iran
[2] Babol Univ Med Sci, Cellular & Mol Biol Res Ctr, Hlth Res Inst, Babol, Iran
[3] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran
[4] Univ Tehran Med Sci, Fac Pharm, Dept Pharmaceut Biotechnol, Tehran, Iran
[5] Alborz Univ Med Sci, CinnaGen Med Biotechnol Res Ctr, Karaj, Iran
[6] Univ Tehran Med Sci, Nano Alvand Co, Avicenna Tech Pk, Tehran 1439955991, Iran
关键词
2,4-Dioxochroman; 1,2,3-Triazole; In vitro evaluation; alpha-Glucosidase; In silica docking study; Diabetes; PANCREATIC BETA-CELLS; TYPE-2; MANAGEMENT; HYBRIDS; DESIGN; 1-DEOXYNOJIRIMYCIN; ANTIOXIDANT; METFORMIN; AGENTS;
D O I
10.2174/1385272824999200802181634
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
In this study, a novel series of 2,4-dioxochroman-1,2,3-triazole hybrids 8a-1 was synthesized by click reaction. These compounds were screened against alpha-glucosidase through in vitro and in silico evaluations. All the synthesized hybrids exhibited excellent alpha-glucosidase inhibition in comparison to standard drug acarbose. Representatively, 3-((((1-(3,4-dichlorobenzyl)-1H-1,2,3-triazol-4-yl)methypamino)methylene)chroman-2,4-dione 8h with IC50 = 20.1 +/- 1.5 mu M against alpha-glucosidase, was 37-times more potent than acarbose. Enzyme kinetic study revealed that compound 8h was a competitive inhibitor against alpha-glucosidase. In silica docking study on chloro derivatives 8h, 8g, and 8i were also performed in the active site of alpha-glucosidase. Evaluations on obtained interaction modes and binding energies of these compounds confirmed the results obtained through in vitro alpha-glucosidase inhibition.
引用
收藏
页码:2019 / 2027
页数:9
相关论文
共 73 条
[1]   Design and synthesis of new fused carbazole-imidazole derivatives as anti-diabetic agents: In vitro α-glucosidase inhibition, kinetic, and in silico studies [J].
Adib, Mehdi ;
Peytam, Fariba ;
Shourgeshty, Reihaneh ;
Mohammadi-Khanaposhtani, Maryam ;
Jahani, Mehdi ;
Imanparast, Somaye ;
Faramarzi, Mohammad Ali ;
Larijani, Bagher ;
Moghadamnia, Ali Akbar ;
Esfahani, Ensieh Nasli ;
Bandarian, Fatemeh ;
Mahdavi, Mohammad .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (05) :713-718
[2]   Design, synthesis and in vitro -glucosidase inhibition of novel coumarin-pyridines as potent antidiabetic agents [J].
Adib, Mehdi ;
Peytam, Fariba ;
Rahmanian-Jazi, Mahmoud ;
Mohammadi-Khanaposhtani, Maryam ;
Mahernia, Shabnam ;
Bijanzadeh, Hamid Reza ;
Jahani, Mehdi ;
Imanparast, Somaye ;
Faramarzi, Mohammad Ali ;
Mahdavi, Mohammad ;
Larijani, Bagher .
NEW JOURNAL OF CHEMISTRY, 2018, 42 (21) :17268-17278
[3]   New 6-amino-pyrido[2,3-d]pyrimidine-2,4-diones as novel agents to treat type 2 diabetes: A simple and efficient synthesis, α-glucosidase inhibition, molecular modeling and kinetic study [J].
Adib, Mehdi ;
Peytam, Fariba ;
Rahmanian-Jazi, Mahmoud ;
Mahernia, Shabnam ;
Bijanzadeh, Hamid Reza ;
Jahani, Mehdi ;
Mohammadi-Khanaposhtani, Maryam ;
Imanparast, Somaye ;
Faramarzi, Mohammad Ali ;
Mahdavi, Mohammad ;
Larijani, Bagher .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 155 :353-363
[4]   Epidemiology of Type 1 Diabetes in Latin America [J].
Angelica Gomez-Diaz, Rita ;
Garibay-Nieto, Nayely ;
Wacher-Rodarte, Niels ;
Alberto Aguilar-Salinas, Carlos .
CURRENT DIABETES REVIEWS, 2014, 10 (02) :75-85
[5]   Synthesis and biological evaluation of new benzimidazole-1,2,3-triazole hybrids as potential α-glucosidase inhibitors [J].
Asemanipoor, Nafise ;
Mohammadi-Khanaposhtani, Maryam ;
Moradi, Shahram ;
Vahidi, Mahbobeh ;
Asadi, Mehdi ;
Faramarzi, Mohammad Ali ;
Mahdavi, Mohammad ;
Biglar, Mahmood ;
Larijani, Bagher ;
Hamedifar, Haleh ;
Hajimiri, Mir Hamed .
BIOORGANIC CHEMISTRY, 2020, 95
[6]   Design and synthesis of 4,5-diphenyl-imidazol-1,2,3-triazole hybrids as new anti-diabetic agents: in vitro α-glucosidase inhibition, kinetic and docking studies [J].
Asgari, Mohammad Sadegh ;
Mohammadi-Khanaposhtani, Maryam ;
Sharafi, Zeinab ;
Faramarzi, Mohammad Ali ;
Rastegar, Hossein ;
Esfahani, Ensieh Nasli ;
Bandarian, Fatemeh ;
Rashidi, Parviz Ranjbar ;
Rahimi, Rahmatollah ;
Biglar, Mahmood ;
Mandavi, Mohammad ;
Larijani, Bagher .
MOLECULAR DIVERSITY, 2021, 25 (02) :877-888
[7]   Biscoumarin-1,2,3-triazole hybrids as novel anti-diabetic agents: Design, synthesis, in vitro α-glucosidase inhibition, kinetic, and docking studies [J].
Asgari, Mohammad Sadegh ;
Mohammadi-Khanaposhtani, Maryam ;
Kiani, Mitra ;
Ranjbar, Parviz Rashidi ;
Zabihi, Ebrahim ;
Pourbagher, Roghayeh ;
Rahimi, Rahmatollah ;
Faramarzi, Mohammad Ali ;
Biglar, Mahmood ;
Larijani, Bagher ;
Mahdavi, Mohammad ;
Hamedifar, Haleh ;
Hajimiri, Mir Hamed .
BIOORGANIC CHEMISTRY, 2019, 92
[8]   New thiosemicarbazide-1,2,3-triazole hybrids as potent α-glucosidase inhibitors: Design, synthesis, and biological evaluation [J].
Bakherad, Zohreh ;
Mohammadi-Khanaposhtani, Maryam ;
Sadeghi-Aliabadi, Hojjat ;
Rezaei, Sepideh ;
Fassihi, Afshin ;
Bakherad, Mohammad ;
Rastegar, Hossein ;
Biglar, Mahmood ;
Saghaie, Lotfollah ;
Larijani, Bagher ;
Mahdavi, Mohammad .
JOURNAL OF MOLECULAR STRUCTURE, 2019, 1192 :192-200
[9]  
BISCHOFF H, 1994, EUR J CLIN INVEST, V24, P3
[10]   Design of SGLT2 Inhibitors for the Treatment of Type 2 Diabetes: A History Driven by Biology to Chemistry [J].
Cai, Wenqing ;
Jiang, Linlin ;
Xie, Yafei ;
Liu, Yuqiang ;
Liu, Wei ;
Zhao, Guilong .
MEDICINAL CHEMISTRY, 2015, 11 (04) :317-328